Related Experiment Videos
Radioassay for serum and red cell folate
The Journal of Laboratory and Clinical Medicine
|January 1, 1976
Summary
A new radioassay for serum and red cell folate is described. This method uses milk as a binder, offering a simpler and more reliable alternative to existing folate assays.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Analytical Chemistry
Background:
- Accurate folate measurement is crucial for diagnosing and managing folate-deficiency anemias and related health conditions.
- Existing folate assays, such as microbiologic methods, can be affected by various medications, leading to inaccurate results.
- The need for a simple, reliable, and less interference-prone assay for serum and red cell folate remains.
Purpose of the Study:
- To develop and describe a novel, simple, and reliable radioassay for determining serum and red cell folate levels.
- To utilize readily available materials like milk as a binder in the folate assay.
- To overcome limitations of existing folate assays, particularly interference from medications.
Main Methods:
- A radioassay employing 125I-tyramide of pteroylglutamic acid (PGA) as the radiolabeled tracer.
- Utilization of plain, untreated liquid or powdered milk as a folate binder, eliminating the need for endogenous serum folate binder.
- Assay performed at pH 9.3 to allow the use of stable PGA standards instead of unstable methyltetrahydrofolic acid (MeTHFA).
Main Results:
- The milk-based radioassay demonstrated comparable results to the standard Lactobacillus casei microbiologic method.
- The assay successfully avoided false low results caused by antibiotics, tranquilizers, and chemotherapeutic agents.
- The method simplifies radioactivity counting using a gamma-emitting isotope.
Conclusions:
- The described radioassay provides a simple, reliable, and robust method for measuring serum and red cell folate.
- Milk serves as an effective and accessible binder, simplifying the assay procedure.
- This assay offers an advantage over existing methods by minimizing interference from common medications.